Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223 Treatment
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 17 Mar 2017
At a glance
- Drugs Radium 223 chloride (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Biomarker; Pharmacodynamics
- 07 Jun 2017 Biomarkers information updated
- 14 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 21 Feb 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Dec 2017.